{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:31:33Z","timestamp":1780086693197,"version":"3.54.0"},"reference-count":340,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"am","delay-in-days":255,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046794"],"award-info":[{"award-number":["R01DA046794"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007904","name":"Texas A and M University","doi-asserted-by":"publisher","award":["R01DA046794"],"award-info":[{"award-number":["R01DA046794"]}],"id":[{"id":"10.13039\/100007904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pnpbp.2024.111137","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T02:19:47Z","timestamp":1725934787000},"page":"111137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mother's little helper turned a foe: Alprazolam use, misuse, and abuse"],"prefix":"10.1016","volume":"136","author":[{"given":"Astrid M.","family":"Cardona-Acosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Meisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan I.","family":"Vardeleon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Bola\u00f1os-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3402\/ljm.v2i4.4727","article-title":"Effects of calcium channel blockers on antidepressant action of alprazolam and imipramine","volume":"2","author":"Aburawi","year":"2007","journal-title":"Libyan J. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-2999(93)90809-V","article-title":"Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release","volume":"230","author":"Acquas","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb0020","first-page":"245","article-title":"Alprazolam compared to diazepam and placebo in the treatment of anxiety","volume":"41","author":"Aden","year":"1980","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1530-0277.1994.tb00053.x","article-title":"Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings","volume":"18","author":"Adinoff","year":"1994","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s12889-019-6933-8","article-title":"Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort","volume":"19","author":"Airagnes","year":"2019","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","article-title":"A review of alprazolam use, misuse, and withdrawal","volume":"12","author":"Ait-Daoud","year":"2018","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psyneuen.2015.04.022","article-title":"Estradiol levels modulate brain activity and negative responses to psychosocial stress across the menstrual cycle","volume":"59","author":"Albert","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.psychres.2016.04.040","article-title":"Motivational drive and alprazolam misuse: A recipe for aggression?","volume":"240","author":"Albrecht","year":"2016","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0163-7258(03)00029-9","article-title":"Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence","volume":"98","author":"Allison","year":"2003","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0060","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/17425255.2013.759209","article-title":"Understanding the pharmacokinetics of anxiolytic drugs","volume":"9","author":"Altamura","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bib1693","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-1014486","article-title":"Preference for alprazolam as opposed to diazepam in benzodiazepine-dependent psychiatric inpatients","volume":"23","author":"Apelt","year":"1990","journal-title":"Pharmacopsychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2024.111137_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0740-5472(91)90023-4","article-title":"Protracted withdrawal syndromes from benzodiazepines","volume":"8","author":"Ashton","year":"1991","journal-title":"J. Subst. Abus. Treat."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"Ashton","year":"2005","journal-title":"Curr. Opin. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00003495-200464040-00004","article-title":"SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations","volume":"64","author":"Asnis","year":"2004","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bib1688","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1037\/0735-7044.108.3.573","article-title":"Benzodiazepine-induced outcome revaluation and the motivational control of instrumental action in rats","volume":"108","author":"Balleine","year":"1994","journal-title":"Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment","volume":"45","author":"Ballenger","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108854","article-title":"Opioid deaths involving concurrent benzodiazepine use: assessing risk factors through the analysis of prescription drug monitoring data and postmortem toxicology","volume":"225","author":"Bannon","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111137_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124445","article-title":"Regulation of GABA(A) receptor subunit expression in substance use disorders","volume":"21","author":"Barker","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0074-7742(08)60663-7","article-title":"Use-dependent regulation of GABAA receptors","volume":"39","author":"Barnes","year":"1996","journal-title":"Int. Rev. Neurobiol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1874473710801030255","article-title":"What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations","volume":"1","author":"Barrett","year":"2008","journal-title":"Curr. Drug Abuse Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612023396681","article-title":"Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal","volume":"8","author":"Bateson","year":"2002","journal-title":"Curr. Pharm. Des."},{"issue":"13","key":"10.1016\/j.pnpbp.2024.111137_bb0120","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/neu.20327","article-title":"ERK\/MAPK pathway regulates GABAA receptors","volume":"66","author":"Bell-Horner","year":"2006","journal-title":"J. Neurobiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0924-977X(00)00137-1","article-title":"Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam","volume":"11","author":"Bentu\u00e9-Ferrer","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0091-3057(86)90341-2","article-title":"Chlordiazepoxide directly enhances positive ingestive reactions in rats","volume":"24","author":"Berridge","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/jpet.122.001191","article-title":"Self-Administration of Fentanyl-Alprazolam Combinations by Rhesus monkeys responding under a progressive-ratio schedule","volume":"383","author":"Berro","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0140","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0022-3565(24)36707-2","article-title":"Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects","volume":"281","author":"Bertz","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5950","key":"10.1016\/j.pnpbp.2024.111137_bb0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/bmj.1.5950.148","article-title":"Letter: Outmoded barbiturates","volume":"1","author":"Birdwood","year":"1975","journal-title":"Br. Med. J."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0150","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/PL00005485","article-title":"Serotonin and tolerance to delay of reward in rats","volume":"146","author":"Bizot","year":"1999","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0155","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12174","article-title":"Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the United States","volume":"79","author":"Blanco","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.peptides.2015.10.009","article-title":"Endogenous opiates and behavior: 2014","volume":"75","author":"Bodnar","year":"2016","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111137_bb0165","doi-asserted-by":"crossref","first-page":"30","DOI":"10.15288\/jsas.1993.s11.30","article-title":"The combination of alprazolam and alcohol on behavioral aggression","volume":"Supplement","author":"Bond","year":"1993","journal-title":"J. Stud. Alcohol"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0327(95)00053-4","article-title":"Behavioural aggression in panic disorder after 8 weeks\u2019 treatment with alprazolam","volume":"35","author":"Bond","year":"1995","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2146\/ajhp060403","article-title":"Buprenorphine for the treatment of opioid dependence","volume":"64","author":"Boothby","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/bjp.2008.133","article-title":"A neuropeptide-centric view of psychostimulant addiction","volume":"154","author":"Boutrel","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102507","article-title":"Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review","volume":"70","author":"Brandt","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0190","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/acschemneuro.8b00268","article-title":"Local GABA(A) receptor-mediated suppression of dopamine release within the nucleus Accumbens","volume":"10","author":"Brodnik","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0195","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1046\/j.1471-4159.1998.71031232.x","article-title":"Gamma-aminobutyric acidA receptor function is desensitised in rat cultured cerebellar granule cells following chronic flunitrazepam treatment","volume":"71","author":"Brown","year":"1998","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111137_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015870","article-title":"Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation","volume":"5","author":"Brown","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111137_bb0205","first-page":"837","article-title":"A review of alprazolam withdrawal","volume":"20","author":"Browne","year":"1986","journal-title":"Drug Intell. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.amepre.2019.07.006","article-title":"Prescription benzodiazepine use in privately insured U.S. children and adolescents","volume":"57","author":"Bushnell","year":"2019","journal-title":"Am. J. Prev. Med."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111137_bb0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.43215","article-title":"Association of Benzodiazepine treatment for sleep disorders with drug overdose risk among young people","volume":"5","author":"Bushnell","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/clpt.1994.55","article-title":"Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans","volume":"55","author":"Busto","year":"1994","journal-title":"Clin. Pharmacol. Therap."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0225","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1038\/s41598-023-37696-8","article-title":"Alprazolam exposure during adolescence induces long-lasting dysregulation in reward sensitivity to morphine and second messenger signaling in the VTA-NAc pathway","volume":"13","author":"Cardona-Acosta","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0230","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.biopsych.2019.04.011","article-title":"Neurobiology of resilience: interface between mind and body","volume":"86","author":"Cathomas","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb0235","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuron.2022.01.033","article-title":"Beyond the neuron: role of non-neuronal cells in stress disorders","volume":"110","author":"Cathomas","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116329","article-title":"Exploring clinical applications and long-term effectiveness of benzodiazepines: an integrated perspective on mechanisms, imaging, and personalized medicine","volume":"173","author":"Chang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0245","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1067\/S0002-9378(03)00756-7","article-title":"Effects from prenatal exposure to alprazolam on the social behavior of mice offspring","volume":"189","author":"Christensen","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0250","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/009127009703700111","article-title":"Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone","volume":"37","author":"Ciraulo","year":"1997","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0255","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0091-3057(83)90456-2","article-title":"Combined effects of chlordiazepoxide treatment and food deprivation on concurrent measures of feeding and activity","volume":"18","author":"Cole","year":"1983","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0260","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/da.20006","article-title":"Effects of buspirone and alprazolam treatment on the startle-potentiated startle response","volume":"19","author":"Commissaris","year":"2004","journal-title":"Depress. Anxiety"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.appet.2005.01.003","article-title":"Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes","volume":"44","author":"Cooper","year":"2005","journal-title":"Appetite"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0270","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0149-7634(85)90028-4","article-title":"Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors","volume":"9","author":"Cooper","year":"1985","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"504","key":"10.1016\/j.pnpbp.2024.111137_bb0275","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1192\/bjp.113.504.1237","article-title":"The biochemistry of affective disorders","volume":"113","author":"Coppen","year":"1967","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0280","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tins.2014.02.002","article-title":"Illicit dopamine transients: reconciling actions of abused drugs","volume":"37","author":"Covey","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0285","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drugpo.2019.01.016","article-title":"Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis","volume":"73","author":"Cunliffe","year":"2019","journal-title":"Int. J. Drug Policy"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0290","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ntt.2004.03.009","article-title":"A population-based case\u2013control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities","volume":"26","author":"Czeizel","year":"2004","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2014.01.023","article-title":"Circumstances and toxicology of sudden or unnatural deaths involving alprazolam","volume":"138","author":"Darke","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0300","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2165\/00003495-198427020-00002","article-title":"Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression","volume":"27","author":"Dawson","year":"1984","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0305","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-008-1134-7","article-title":"Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray","volume":"198","author":"de Bortoli","year":"2008","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0310","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00213-002-1376-8","article-title":"Benzodiazepines: more \"behavioural\" addiction than dependence","volume":"167","author":"De Las Cuevas","year":"2003","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2004.04.002","article-title":"Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome","volume":"76","author":"De Wet","year":"2004","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2024.111137_bb0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","article-title":"Dopamine and drug addiction: the nucleus accumbens shell connection","volume":"47","author":"Di Chiara","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.therap.2023.02.002","article-title":"Alprazolam misuse: analysis of French Addictovigilance network data from 2011 to 2020","author":"Diaz","year":"2023","journal-title":"Therapie"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3758\/BF03199951","article-title":"Motivational control of goal-directed action","volume":"22","author":"Dickinson","year":"1994","journal-title":"Anim. Learn. Behav."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0335","article-title":"Prescribed benzodiazepines and suicide risk: A review of the literature","volume":"19","author":"Dodds","year":"2017","journal-title":"Prim Care Compan. CNS Disord"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0340","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00000433-199612000-00012","article-title":"Sudden death and benzodiazepines","volume":"17","author":"Drummer","year":"1996","journal-title":"Am J Forensic Med Pathol"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0345","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-006-0431-2","article-title":"Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes","volume":"187","author":"Duke","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108985","article-title":"Tolerance and dependence following chronic alprazolam treatment in rhesus monkeys: role of GABA(A) receptor subtypes","volume":"228","author":"Duke","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112935","article-title":"Differential effects of alprazolam against methylphenidate-induced neurobehavioral alterations","volume":"222","author":"Dutt","year":"2020","journal-title":"Physiol. Behav."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0360","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/1049731506291582","article-title":"Limitations of the patient health questionnaire in identifying anxiety and depression: many cases are undetected","volume":"16","author":"Eack","year":"2006","journal-title":"Res. Soc. Work. Pract."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0365","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol. Int."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0370","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/10550887.2022.2042152","article-title":"An examination of correlates of simultaneous opioid and benzodiazepine use among patients in medication treatment for opioid use disorder in a small midwestern community","volume":"40","author":"Ellis","year":"2022","journal-title":"J. Addict. Dis."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111137_bb0375","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/npp.2014.41","article-title":"Neural basis of benzodiazepine reward: requirement for alpha2 containing GABAA receptors in the nucleus accumbens","volume":"39","author":"Engin","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111137_bb0380","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.59.9.851","article-title":"Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study","volume":"59","author":"Epperson","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0385","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00008877-200209000-00016","article-title":"The effects of alprazolam and buspirone in light and moderate female social drinkers","volume":"13","author":"Evans","year":"2002","journal-title":"Behav. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0390","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/appe.1998.0222","article-title":"Food \u201ccravings\u201d and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder","volume":"32","author":"Evans","year":"1999","journal-title":"Appetite"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0395","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0400","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuroscience.2015.09.038","article-title":"Tolerance to the sedative and anxiolytic effects of diazepam is associated with different alterations of GABAA receptors in rat cerebral cortex","volume":"310","author":"Ferreri","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0149-7634(85)90037-5","article-title":"Tolerance to the behavioral actions of benzodiazepines","volume":"9","author":"File","year":"1985","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0410","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF02801973","article-title":"Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration","volume":"106","author":"Finlay","year":"1992","journal-title":"Psychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2024.111137_bb0415","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0014-2999(92)90123-L","article-title":"Antidepressant and anxiolytic effects of alprazolam versus the conventional antidepressant desipramine and the anxiolytic diazepam in the forced swim test in rats","volume":"214","author":"Flugy","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0420","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/15412555.2015.1007932","article-title":"Trends in outpatient visits with benzodiazepines among US adults with and without bronchitis or chronic obstructive pulmonary disease from 1999 to 2010","volume":"12","author":"Ford","year":"2015","journal-title":"COPD: J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0425","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2019.02.016","article-title":"GABAA\/benzodiazepine receptors in the dorsal periaqueductal gray mediate the panicolytic but not the anxiolytic effect of alprazolam in rats","volume":"364","author":"Frias","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb0430","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/15563650.2019.1674321","article-title":"Child and adolescent benzodiazepine exposure and overdose in the United States: 16 years of poison center data","volume":"58","author":"Friedrich","year":"2020","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0435","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1476-5381.1990.tb14167.x","article-title":"Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function","volume":"101","author":"Galpern","year":"1990","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0440","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02244183","article-title":"Chronic benzodiazepine administration","volume":"104","author":"Galpern","year":"1991","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0445","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0278-5846(98)00060-8","article-title":"Pharmacological treatment of alcoholism","volume":"22","author":"Gatch","year":"1998","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111137_bb0450","first-page":"390","article-title":"Treatment of recent trauma survivors with benzodiazepines: a prospective study","volume":"57","author":"Gelpin","year":"1996","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0455","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/HRP.0000000000000190","article-title":"Prescription benzodiazepine use among older adults: A critical review","volume":"26","author":"Gerlach","year":"2018","journal-title":"Harv. Rev. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0460","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(97)01608-7","article-title":"Dopamine receptors in the striatum of rats exposed to repeated restraint stress and alprazolam treatment","volume":"344","author":"Giardino","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0470","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(93)90493-D","article-title":"Effects of alprazolam on intravenous cocaine self-administration in rats","volume":"44","author":"Goeders","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0475","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00213-002-1019-0","article-title":"Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys","volume":"161","author":"Gomez","year":"2002","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0480","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/acschemneuro.6b00358","article-title":"Diazepam inhibits electrically evoked and tonic dopamine release in the nucleus Accumbens and reverses the effect of amphetamine","volume":"8","author":"Gomez","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0485","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phrs.2015.12.030","article-title":"Activation-induced regulation of GABAA receptors: is there a link with the molecular basis of benzodiazepine tolerance?","volume":"109","author":"Gravielle","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0490","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(96)00599-7","article-title":"Effect of alprazolam on opiate withdrawal: a combined behavioural and microdialysis study","volume":"313","author":"Gray","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111137_bb0495","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1532-5415.2003.51502.x","article-title":"Benzodiazepine use and physical performance in community-dwelling older women","volume":"51","author":"Gray","year":"2003","journal-title":"J. Am. Geriatr. Soc."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0500","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00003088-199324060-00003","article-title":"Clinical pharmacokinetics of alprazolam. Therapeutic implications","volume":"24","author":"Greenblatt","year":"1993","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0505","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/clpt.1992.175","article-title":"Fluoxetine impairs clearance of alprazolam but not of clonazepam","volume":"52","author":"Greenblatt","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0510","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3565(24)39253-5","article-title":"Comparative kinetics and response to the benzodiazepine agonists Triazolam and zolpidem: evaluation of sex-dependent differences","volume":"293","author":"Greenblatt","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0515","first-page":"1103739","article-title":"Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder","volume":"14","author":"Greenwald","year":"2023","journal-title":"Front. Psychol."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111137_bb0520","article-title":"Benzodiazepine overuse in elders: defining the problem and potential solutions","volume":"12","author":"Gress","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0525","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","article-title":"Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse","volume":"134","author":"Griffiths","year":"1997","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0535","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02244196","article-title":"Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons","volume":"103","author":"Griffiths","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0540","author":"Grohol"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7020017","article-title":"Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives","volume":"7","author":"Guina","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0550","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/clinchem\/46.6.889","article-title":"Disposition of toxic drugs and Chemicals in man, 5th ed. R.C. Baselt. Foster City, CA: chemical toxicology institute, 1999, 900 pp., $119.00. ISBN 0-9626523-3-4","volume":"46","author":"Hammett-Stabler","year":"2000","journal-title":"Clin. Chem."},{"issue":"6462","key":"10.1016\/j.pnpbp.2024.111137_bb0555","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.aax5719","article-title":"Shisa7 is a GABA<sub>A<\/sub> receptor auxiliary subunit controlling benzodiazepine actions","volume":"366","author":"Han","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0560","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002130050350","article-title":"Alprazolam increases food intake in humans","volume":"132","author":"Haney","year":"1997","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0565","first-page":"162","article-title":"Anxiety disorders among women: a female lifespan approach","volume":"15","author":"Hantsoo","year":"2017","journal-title":"Focus (Am. Psychiatr. Publ.)"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0570","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hbm.21086","article-title":"Measurement of variation in the human cerebral GABA level by in vivo MEGA-editing proton MR spectroscopy using a clinical 3 T instrument and its dependence on brain region and the female menstrual cycle","volume":"32","author":"Harada","year":"2011","journal-title":"Hum. Brain Mapp."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0575","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/npp.2008.89","article-title":"Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists","volume":"34","author":"Heikkinen","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0580","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1254\/jjp.77.107","article-title":"The role of calcium in the etiology of the affective disorders","volume":"77","author":"Helmeste","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0585","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5694\/j.1326-5377.1993.tb121644.x","article-title":"Experience with 732 acute overdose patients admitted to an intensive care unit over six years","volume":"158","author":"Henderson","year":"1993","journal-title":"Med. J. Aust."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0590","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuroscience.2005.03.065","article-title":"Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens","volume":"135","author":"Hirose","year":"2005","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0595","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/bdd.261","article-title":"In vitro\/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans","volume":"22","author":"Hirota","year":"2001","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0600","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2014.10.013","article-title":"Impairment due to amphetamines and benzodiazepines, alone and in combination","volume":"145","author":"H\u00f8iseth","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0605","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2796.1989.tb01365.x","article-title":"Benzodiazepine poisoning: experience of 702 admissions to an intensive care unit during a 14-year period","volume":"226","author":"Hojer","year":"1989","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0610","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-015-4151-3","article-title":"Ventral tegmental area dopamine revisited: effects of acute and repeated stress","volume":"233","author":"Holly","year":"2016","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0615","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/bcpt.12655","article-title":"The pharmacology and toxicology of the \u2018holy trinity\u2019","volume":"120","author":"Horsfall","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0620","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1465-3362.2011.00381.x","article-title":"The use of alprazolam by people who inject drugs in Melbourne, Australia","volume":"31","author":"Horyniak","year":"2012","journal-title":"Drug Alcohol. Rev."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0625","first-page":"204","article-title":"Cell type-specific gene expression of alpha 5 subunit-containing gamma-aminobutyric acid subtype A receptors in human and mouse frontal cortex","volume":"4","author":"Hu","year":"2019","journal-title":"Molecular Neuropsychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0630","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1523\/JNEUROSCI.14-04-02236.1994","article-title":"Lamina-specific expression and activity-dependent regulation of seven GABAA receptor subunit mRNAs in monkey visual cortex","volume":"14","author":"Huntsman","year":"1994","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111137_bb0635","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.16-11-03571.1996","article-title":"Nucleus-specific expression of GABA<sub>A<\/sub> receptor subunit mRNAs in monkey thalamus","volume":"16","author":"Huntsman","year":"1996","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0640","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/jgs.17709","article-title":"Concurrent use of opioids and benzodiazepines among nursing home and assisted living residents who receive a pain medication","volume":"70","author":"Huskamp","year":"2022","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0645","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0376-8716(93)90090-D","article-title":"Benzodiazepine and sedative use\/abuse by methadone maintenance clients","volume":"32","author":"Iguchi","year":"1993","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0650","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2125.2004.02089.x","article-title":"Alprazolam is relatively more toxic than other benzodiazepines in overdose","volume":"58","author":"Isbister","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0655","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/imj.12315","article-title":"Twenty-year trends in benzodiazepine dispensing in the Australian population","volume":"44","author":"Islam","year":"2014","journal-title":"Intern. Med. J."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0660","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"J. Pharm. Pract."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0665","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J. Neurosci."},{"issue":"25\u201345","key":"10.1016\/j.pnpbp.2024.111137_bb0670","article-title":"A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature","volume":"54 Suppl","author":"Jonas","year":"1993","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0675","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0269881112471155","article-title":"Concentrations of alprazolam in blood from impaired drivers and forensic autopsies were not much different but showed a high prevalence of co-ingested illicit drugs","volume":"27","author":"Jones","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2024.111137_bb0680","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111137_bb0685","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0025-6196(12)60643-0","article-title":"Problems with benzodiazepines in elderly patients","volume":"68","author":"Juergens","year":"1993","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0690","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0741-8329(00)00079-3","article-title":"Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal","volume":"21","author":"Jung","year":"2000","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0695","first-page":"138","article-title":"Midazolam: dose-response studies of effectiveness and rebound insomnia","volume":"26","author":"Kales","year":"1983","journal-title":"Pharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb0700","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/j.1552-4604.1987.tb03058.x","article-title":"Alprazolam: effects on sleep and withdrawal phenomena","volume":"27","author":"Kales","year":"1987","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0705","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1176\/appi.ajp.2020.20030305","article-title":"The critical relationship between anxiety and depression","volume":"177","author":"Kalin","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0710","series-title":"StatPearls [Internet]","article-title":"Benzodiazepine Toxicity. [Updated 2023 Feb 7]","author":"Kang","year":"2023"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0715","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/j.1552-4604.1998.tb04370.x","article-title":"Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects","volume":"38","author":"Kaplan","year":"1998","journal-title":"J. Clin. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2024.111137_bb0720","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K","article-title":"Comorbidity of mood and anxiety disorders","volume":"12","author":"Kaufman","year":"2000","journal-title":"Depress. Anxiety"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0725","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1176\/appi.ps.201700095","article-title":"Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999-2014","volume":"69","author":"Kaufmann","year":"2018","journal-title":"Psychiatr. Serv."},{"issue":"30","key":"10.1016\/j.pnpbp.2024.111137_bb0730","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1192\/S0007125000298437","article-title":"Major depression and generalised anxiety disorder. Same genes, (partly)different environments--revisited","volume":"Suppl","author":"Kendler","year":"1996","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0735","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1176\/ajp.156.6.837","article-title":"Causal relationship between stressful life events and the onset of major depression","volume":"156","author":"Kendler","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0740","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0745","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/clpt.1991.157","article-title":"Influence of menstrual cycle and gender on alprazolam pharmacokinetics","volume":"50","author":"Kirkwood","year":"1991","journal-title":"Clin. Pharmacol. Ther. (St. Louis, MO, U. S.)"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0750","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.pnpbp.2009.05.018","article-title":"Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand","volume":"33","author":"Kita","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0755","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(97)00988-8","article-title":"Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene","volume":"778","author":"Kitchen","year":"1997","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111137_bb0760","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1176\/ajp.151.12.1760","article-title":"Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine","volume":"151","author":"Klein","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0765","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.1988.01800290021003","article-title":"Overview of the cross-national collaborative panic study","volume":"45","author":"Klerman","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0770","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000139531","article-title":"The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation","volume":"55","author":"Koff","year":"2008","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1650","article-title":"Prolonged alprazolam treatment alters components of glutamatergic neurotransmission in the Hippocampus of male Wistar rats-the Neuroadaptive changes following long-term benzodiazepine (Mis)use","volume":"16","author":"Kontic","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb0775","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0028-3908(86)90092-4","article-title":"Effect of chronic administration of alprazolam and adinazolam on clonidine- or apomorphine-induced aggression in laboratory rodents","volume":"25","author":"Kostowski","year":"1986","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0780","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2999(84)90625-3","article-title":"Anxiolytic activity on locus coeruleus-mediated suppression of muricidal aggression","volume":"105","author":"Kozak","year":"1984","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0785","first-page":"249","article-title":"Disposition of alprazolam in human volunteers. Differences between genders","volume":"3","author":"Kristj\u00e1nsson","year":"1991","journal-title":"Acta Pharm. Nord."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111137_bb0790","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11606-016-3740-0","article-title":"Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care","volume":"31","author":"Kroll","year":"2016","journal-title":"J. Gen. Intern. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0795","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0149-7634(98)00017-7","article-title":"Aggressive and social behavior after alprazolam withdrawal: experimental therapy with Ro 19-8022","volume":"23","author":"Krsiak","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0800","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/YIC.0000000000000441","article-title":"Associations of adolescent psychosocial factors to later benzodiazepine use: a population-based follow-up study of adolescent psychiatric inpatients in Northern Finland","volume":"38","author":"Kujala","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111137_bb0805","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns - a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111137_bb0810","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14005","article-title":"Outcome implications of benzodiazepine and opioid co-prescription in kidney transplant recipients","volume":"34","author":"Lam","year":"2020","journal-title":"Clin. Transpl."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0815","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/sleep\/22.1.33","article-title":"Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists","volume":"22","author":"Lancel","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0820","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.40.1.389","article-title":"Molecular mechanisms and regulation of opioid receptor signaling","volume":"40","author":"Law","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110819","article-title":"Houston cocktail: driving under influence of hydrocodone, alprazolam, and carisoprodol","volume":"323","author":"Lee","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0830","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.934265","article-title":"Pregnancy and neonatal outcomes after exposure to alprazolam in pregnancy","volume":"13","author":"Lee","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0835","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-328X(97)00255-6","article-title":"Effects of PKC activation and receptor desensitization on neurosteroid modulation of GABA(A) receptors","volume":"52","author":"Leidenheimer","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0840","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/j.1471-4159.1993.tb13432.x","article-title":"Activation of calcium-phospholipid-dependent protein kinase enhances benzodiazepine and barbiturate potentiation of the GABAA receptor","volume":"60","author":"Leidenheimer","year":"1993","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb0845","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/alcalc\/33.6.563","article-title":"Benzodiazepine treatment for alcohol-dependent patients","volume":"33","author":"Lejoyeux","year":"1998","journal-title":"Alcohol Alcohol."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111137_bb0850","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"Lembke","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0855","doi-asserted-by":"crossref","first-page":"fcz025","DOI":"10.1093\/braincomms\/fcz025","article-title":"Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development","volume":"1","author":"Lerner","year":"2019","journal-title":"Brain Commun."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0860","series-title":"The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill","volume":"vol. 2","author":"Levenson","year":"2011"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0865","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283549","article-title":"Opioid-related deaths during hospital admissions or shortly after discharge in the United Kingdom: a thematic framework analysis of coroner reports","volume":"18","author":"Lewer","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0870","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drugalcdep.2011.06.006","article-title":"Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance","volume":"119","author":"Lile","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2024.111137_bb0875","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-3956(90)90043-P","article-title":"Benzodiazepines and alcohol","volume":"24","author":"Linnoila","year":"1990","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0880","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1530-0277.1991.tb00570.x","article-title":"Pharmacotherapies for alcoholism: promising agents and clinical issues","volume":"15","author":"Litten","year":"1991","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"6002","key":"10.1016\/j.pnpbp.2024.111137_bb0885","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1188472","article-title":"Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward","volume":"330","author":"Lobo","year":"2010","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb0890","first-page":"2121","article-title":"Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives","volume":"61","author":"Longo","year":"2000","journal-title":"Am. Fam. Physician"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0895","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0028-3908(90)90007-E","article-title":"Chronic administration of benzodiazepines\u2014V. Rapid onset of behavioral and neurochemical alterations after discontinuation of alprazolam","volume":"29","author":"Lopez","year":"1990","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0900","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004714-199204000-00007","article-title":"Chronic Low-dose alprazolam augments \u03b3-aminobutyric AcidA receptor function","volume":"12","author":"Lopez","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5489","key":"10.1016\/j.pnpbp.2024.111137_bb0905","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"Low","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0910","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031156","article-title":"Patterns of benzodiazepine prescription among older adults in Switzerland: a cross-sectional analysis of claims data","volume":"10","author":"Luta","year":"2020","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0915","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1046\/j.1471-4159.2001.00501.x","article-title":"Distinct signal transduction pathways for GABA-induced GABA(A) receptor down-regulation and uncoupling in neuronal culture: a role for voltage-gated calcium channels","volume":"78","author":"Lyons","year":"2001","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111137_bb0920","doi-asserted-by":"crossref","first-page":"e910","DOI":"10.1038\/tp.2016.181","article-title":"Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress","volume":"6","author":"Ma","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0925","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ph3010019","article-title":"The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments","volume":"3","author":"Machado-Vieira","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0930","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/00952998209002608","article-title":"Benzodiazepine withdrawal syndrome: a literature review and evaluation","volume":"9","author":"MacKinnon","year":"1982","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"4753","key":"10.1016\/j.pnpbp.2024.111137_bb0935","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb0940","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0004867419900313","article-title":"The delay in response to antidepressant therapy: A window of opportunity?","volume":"54","author":"Malhi","year":"2020","journal-title":"Austral. New Zeal. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0945","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0000000000001669","article-title":"Alprazolam: good for some, not good for all!","volume":"43","author":"Mamtani","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb0950","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.euroneuro.2008.12.004","article-title":"Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD","volume":"19","author":"Matar","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0955","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1465-3362.2011.00291.x","article-title":"The prescription drug epidemic in the United States: a perfect storm","volume":"30","author":"Maxwell","year":"2011","journal-title":"Drug Alcohol Rev."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0960","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.addbeh.2014.01.009","article-title":"Medical and nonmedical use of prescription benzodiazepine anxiolytics among U.S. high school seniors","volume":"39","author":"McCabe","year":"2014","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb0965","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jadohealth.2006.07.016","article-title":"Medical and nonmedical use of prescription drugs among secondary school students","volume":"40","author":"McCabe","year":"2007","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0970","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.drugalcdep.2018.10.027","article-title":"A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife","volume":"194","author":"McCabe","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0975","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.addbeh.2016.08.020","article-title":"Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder","volume":"65","author":"McHugh","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pnpbp.2024.111137_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106608","article-title":"Sex differences in benzodiazepine misuse among adults with substance use disorders","volume":"112","author":"McHugh","year":"2021","journal-title":"Addict. Behav."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb0985","article-title":"Alprazolam withdrawal delirium and brief reversible psychosis: a case report","volume":"16","author":"McKenzie","year":"2014","journal-title":"Prim Care Compan. CNS Disord"},{"key":"10.1016\/j.pnpbp.2024.111137_bb0990","article-title":"Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification","volume":"67","author":"McLean","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111137_bb0995","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","article-title":"Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A)","volume":"49","author":"Merikangas","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111137_bb1000","first-page":"139","article-title":"Alcohol, GABAA-benzodiazepine receptor complex, and aggression","volume":"13","author":"Miczek","year":"1997","journal-title":"Recent Dev. Alcohol."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1005","article-title":"Receptor subtypes: novel targets for novel medicines","volume":"2012","author":"Mirza","year":"2012","journal-title":"Adv. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1519\/JPT.0000000000000264","article-title":"Performance and clinimetric properties of the timed up from floor test completed by apparently healthy community-dwelling older women","volume":"44","author":"Moffett","year":"2021","journal-title":"J. Geriatr. Phys. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn.2016.165","article-title":"Ventral tegmental area: cellular heterogeneity, connectivity and behaviour","volume":"18","author":"Morales","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0009-9236(95)90162-0","article-title":"Alprazolam absorption kinetics affects abuse liability","volume":"57","author":"Mumford","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3565(25)24438-X","article-title":"Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects","volume":"272","author":"Mumford","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1037\/1064-1297.3.1.39","article-title":"Alprazolam and DN-2327 (Pazinaclone) in humans: psychomotor, memory, subjective, and reinforcing effects","volume":"3","author":"Mumford","year":"1995","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-169","article-title":"Physician guide to appropriate opioid prescribing for noncancer pain","volume":"21","author":"Munzing","year":"2017","journal-title":"Perm. J."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1040","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11096-015-0138-8","article-title":"Benzodiazepine prescribing guideline adherence and misuse potential in Irish minors","volume":"37","author":"Murphy","year":"2015","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1050","series-title":"NICE guideline (CG192)","year":"2014"},{"key":"10.1016\/j.pnpbp.2024.111137_bb1055","series-title":"Sleep Statistics","author":"National Council on Aging","year":"2022"},{"key":"10.1016\/j.pnpbp.2024.111137_bib1689","series-title":"Overdose death rates","year":"2024"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111137_bb1060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1185\/03007999009112688","article-title":"Opiate dependence--the role of benzodiazepines","volume":"11","author":"Navaratnam","year":"1990","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","article-title":"Molecular basis of long-term plasticity underlying addiction","volume":"2","author":"Nestler","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111137_bb1070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1075","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1360-0443.2006.01731.x","article-title":"Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment","volume":"102","author":"Nielsen","year":"2007","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1080","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bcpt.12706","article-title":"Trends in off-label prescribing of sedatives, hypnotics and antidepressants among children and adolescents - A Danish, Nationwide register-based study","volume":"120","author":"Nielsen","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6698","key":"10.1016\/j.pnpbp.2024.111137_bb1085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/25999","article-title":"Increased number of synaptic GABA(A) receptors underlies potentiation at hippocampal inhibitory synapses","volume":"395","author":"Nusser","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00213-005-0185-2","article-title":"Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders","volume":"186","author":"N-Wihlback,","year":"2006","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb1090","first-page":"Cd001026","article-title":"Antidepressants plus benzodiazepines for adults with major depression","volume":"6","author":"Ogawa","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3\u20134","key":"10.1016\/j.pnpbp.2024.111137_bb1095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000346440","article-title":"Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence","volume":"91","author":"Okamoto","year":"2013","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0924-977X(91)90709-4","article-title":"Ethopharmacological studies of anxiolytics and aggression","volume":"1","author":"Olivier","year":"1991","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/10826088809039211","article-title":"Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo","volume":"23","author":"Orzack","year":"1988","journal-title":"Int. J. Addict."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0022-3565(25)20232-4","article-title":"The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal","volume":"258","author":"Owens","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1120","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/10253890.2017.1369523","article-title":"Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: sex differences in regulation of stress responsivity","volume":"20","author":"Oyola","year":"2017","journal-title":"Stress"},{"key":"10.1016\/j.pnpbp.2024.111137_bb1125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugpo.2019.01.021","article-title":"Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: a population-level cohort study","volume":"67","author":"Parent","year":"2019","journal-title":"Int. J. Drug Policy"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111137_bb1130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1192\/pb.26.12.460","article-title":"Benzodiazepines and disinhibition: a review","volume":"26","author":"Paton","year":"2002","journal-title":"Psychiatr. Bull."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1135","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.1367","article-title":"Trends in psychotropic medication use among U.S. adults","volume":"16","author":"Paulose-Ram","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archpsyc.1988.01800290043006","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects","volume":"45","author":"Pecknold","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bcpt.12434","article-title":"Adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication--a systematic review with meta-analyses of randomised trials","volume":"118","author":"Penninga","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-0327(84)90018-1","article-title":"Plasma GABA levels in psychiatric illness","volume":"6","author":"Petty","year":"1984","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111137_bb1155","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","article-title":"The benzodiazepine withdrawal syndrome","volume":"89","author":"Petursson","year":"1994","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-013-3224-4","article-title":"A multistep general theory of transition to addiction","volume":"229","author":"Piazza","year":"2013","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0361-9230(96)00265-1","article-title":"Antinociceptive interaction between alprazolam and opioids","volume":"42","author":"Pick","year":"1997","journal-title":"Brain Res. Bull."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb1170","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jama.279.7.526","article-title":"Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties","volume":"279","author":"Pincus","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1254\/jphs.08249FP","article-title":"Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced mu-opioid receptor regulation","volume":"110","author":"Poisnel","year":"2009","journal-title":"J. Pharmacol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2024.111137_bb1180","first-page":"21","article-title":"Chlordiazepoxide and food-deprivation compared using a food-preference test in the rat","volume":"11","author":"Posadas-Andrews","year":"1985","journal-title":"Revista Mexicana de An\u00e1lisis de la Conducta"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/1043-6618(94)80096-0","article-title":"Anxiolytic profiles of alprazolam and ethanol in the elevated plus-maze test and the early acquisition of shuttlebox avoidance","volume":"29","author":"Prunell","year":"1994","journal-title":"Pharmacol. Res."},{"issue":"Pt B","key":"10.1016\/j.pnpbp.2024.111137_bb1190","article-title":"Status epilepticus in pregnancy - Can we frame a uniform treatment protocol?","volume":"101","author":"Rajiv","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"3 Suppl","key":"10.1016\/j.pnpbp.2024.111137_bb1195","first-page":"7","article-title":"Pharmacology of methaminodiazepoxide","volume":"21","author":"Randall","year":"1960","journal-title":"Dis. Nerv. Syst."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-3565(25)25804-9","article-title":"The psychosedative properties of methaminodiazepoxide","volume":"129","author":"Randall","year":"1960","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00213-014-3721-0","article-title":"Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potential","volume":"232","author":"Reissig","year":"2015","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb1210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1081\/CLT-120026520","article-title":"Comparison of the fatal toxicity index of zopiclone with benzodiazepines","volume":"41","author":"Reith","year":"2003","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111137_bb1215","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/npp.2012.115","article-title":"Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward","volume":"37","author":"Reynolds","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb1220","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1517\/14656566.5.7.1599","article-title":"Alprazolam extended-release in panic disorder","volume":"5","author":"Rickels","year":"2004","journal-title":"Expert. Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","article-title":"Benzodiazepines in epilepsy: pharmacology and pharmacokinetics","volume":"118","author":"Riss","year":"2008","journal-title":"Acta Neurol. Scand."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1230","first-page":"206","article-title":"Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder","volume":"51","author":"Risse","year":"1990","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0376-8716(97)01354-9","article-title":"Alprazolam-reinforced medication use in outpatients with anxiety","volume":"45","author":"Roache","year":"1997","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1240","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0026-895X(25)10901-2","article-title":"Gamma-aminobutyric acid A receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines","volume":"37","author":"Roca","year":"1990","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cns.12489","article-title":"Pharmacotherapy for alcohol dependence: the 2015 recommendations of the French alcohol society, issued in partnership with the European Federation of Addiction Societies","volume":"22","author":"Rolland","year":"2016","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb1250","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1176\/ajp.141.6.792","article-title":"Emergence of hostility during alprazolam treatment","volume":"141","author":"Rosenbaum","year":"1984","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1255","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb1260","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1176\/ajp.146.7.860","article-title":"Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam","volume":"146","author":"Roy-Byrne","year":"1989","journal-title":"Am. J. Psychiatry"},{"issue":"6755","key":"10.1016\/j.pnpbp.2024.111137_bb1265","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1270","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.jcp.0000130553.55630.ad","article-title":"Alprazolam attenuates the behavioral effects of d-amphetamine in humans","volume":"24","author":"Rush","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"issue":"15","key":"10.1016\/j.pnpbp.2024.111137_bb1275","doi-asserted-by":"crossref","first-page":"8600","DOI":"10.1073\/pnas.97.15.8600","article-title":"An initiator element mediates autologous downregulation of the human type A gamma -aminobutyric acid receptor beta 1 subunit gene","volume":"97","author":"Russek","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111137_bb1280","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","article-title":"Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy","volume":"56","author":"Sanacora","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.pnpbp.2024.111137_bb1285","first-page":"41","article-title":"Antidepressant adherence: are patients taking their medications?","volume":"9","author":"Sansone","year":"2012","journal-title":"Innov. Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1290","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00004714-198710000-00008","article-title":"Alprazolam kinetics following sublingual and oral administration","volume":"7","author":"Scavone","year":"1987","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111137_bb1295","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.11590","article-title":"Comparison of prescribing patterns before and after implementation of a National Policy to reduce inappropriate alprazolam prescribing in Australia","volume":"2","author":"Schaffer","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1300","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.117.241802","article-title":"Diazepam concurrently increases the frequency and decreases the amplitude of transient dopamine release events in the nucleus accumbens","volume":"364","author":"Schelp","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.addbeh.2015.08.002","article-title":"Prevalence and correlates of co-ingestion of prescription tranquilizers and other psychoactive substances by U.S. high school seniors: results from a national survey","volume":"52","author":"Schepis","year":"2016","journal-title":"Addict. Behav."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb1310","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaac.2018.09.438","article-title":"Prescription drug misuse: sources of controlled medications in adolescents","volume":"58","author":"Schepis","year":"2019","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1315","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/ADM.0000000000000736","article-title":"Prescription tranquilizer\/sedative misuse motives across the US population","volume":"15","author":"Schepis","year":"2021","journal-title":"J. Addict. Med."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1320","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111137_bb1325","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yebeh.2018.07.027","article-title":"Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: a randomized, double-blind, controlled trial","volume":"88","author":"Schoedel","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111137_bb1330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006585","article-title":"Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression","volume":"4","author":"Sequeira","year":"2009","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2024.111137_bb1335","first-page":"S27","article-title":"Characteristics of alprazolam-related deaths compiled by a centralized state medical examiner","volume":"21","author":"Shah","year":"2012","journal-title":"Am. J. Addict."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111137_bb1340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002635","article-title":"Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study","volume":"15","author":"Sidorchuk","year":"2018","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111137_bb1345","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026023393507","article-title":"Subunit composition, distribution and function of GABA(A) receptor subtypes","volume":"2","author":"Sieghart","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111137_bb1350","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2174\/1568026023393444","article-title":"Mapping of the benzodiazepine recognition site on GABA(A) receptors","volume":"2","author":"Sigel","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111137_bb1355","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0165-6147(97)01118-8","article-title":"The benzodiazepine binding site of GABAA receptors","volume":"18","author":"Sigel","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1360","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neures.2007.12.003","article-title":"Protective effect of alprazolam against sleep deprivation-induced behavior alterations and oxidative damage in mice","volume":"60","author":"Singh","year":"2008","journal-title":"Neurosci. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1365","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/2348-9995.195605","article-title":"Benzodiazepine abuse among the elderly [review article]","volume":"3","author":"Singh","year":"2016","journal-title":"J. Geriatr. Mental Health"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2024.111137_bb1370","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02791072.1983.10472127","article-title":"Benzodiazepine dependency syndromes","volume":"15","author":"Smith","year":"1983","journal-title":"J. Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1375","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF00431449","article-title":"Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration","volume":"84","author":"Smith","year":"1984","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111137_bb1380","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/WNL.53.9.2069","article-title":"Menstrual cycle effects on cortical excitability","volume":"53","author":"Smith","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1385","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0386-18.2018","article-title":"Nucleus accumbens microcircuit underlying D2-MSN-driven increase in motivation","volume":"5","author":"Soares-Cunha","year":"2018","journal-title":"eNeuro"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110380","article-title":"Distinct role of nucleus accumbens D2-MSN projections to ventral pallidum in different phases of motivated behavior","volume":"38","author":"Soares-Cunha","year":"2022","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb1395","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1400","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1405","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2016.07.015","article-title":"The differential effects of alprazolam and oxazepam on methamphetamine self-administration in rats","volume":"166","author":"Spence","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1410","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2016.07.015","article-title":"The differential effects of alprazolam and oxazepam on methamphetamine self-administration in rats","volume":"166","author":"Spence","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1415","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuropharm.2015.10.041","article-title":"Differential modulation of the discriminative stimulus effects of methamphetamine and cocaine by alprazolam and oxazepam in male and female rats","volume":"102","author":"Spence","year":"2016","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb1420","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1097\/00004714-199912002-00004","article-title":"Psychological strategies for discontinuing benzodiazepine treatment","volume":"19","author":"Spiegel","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb1425","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40263-013-0084-8","article-title":"Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management","volume":"27","author":"Spiller","year":"2013","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1430","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1592\/phco.27.3.389","article-title":"Clinical pharmacokinetic monitoring of midazolam in critically ill patients","volume":"27","author":"Spina","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pnpbp.2024.111137_bb1435","series-title":"Prescriber\u2019 S Guide: Stahl\u2019 S Essential Psychopharmacology","author":"Stahl","year":"2020"},{"key":"10.1016\/j.pnpbp.2024.111137_bb1440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2016.06.008","article-title":"Reasons for benzodiazepine use among persons seeking opioid detoxification","volume":"68","author":"Stein","year":"2016","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1445","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2017.03.002","article-title":"Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder","volume":"77","author":"Stein","year":"2017","journal-title":"J. Subst. Abus. Treat."},{"issue":"14","key":"10.1016\/j.pnpbp.2024.111137_bb1450","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1073\/pnas.90.14.6889","article-title":"Diazepam dependence prevented by glutamate antagonists","volume":"90","author":"Steppuhn","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2024.111137_bb1455","first-page":"229","article-title":"The benzodiazepine story","volume":"22","author":"Sternbach","year":"1978","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.pnpbp.2024.111137_bib1691","unstructured":"Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2024.111137_bb1460","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2008.10.015","article-title":"Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder","volume":"101","author":"Subramaniam","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111137_bib1692","series-title":"Results from the 2018 National Survey on Drug Use and Health: Detailed tables","year":"2019"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111137_bb1045","first-page":"578","article-title":"The teratogenic effects of alprazolam intake on rat fetus","volume":"68","author":"Takzare","year":"2011","journal-title":"Tehran University Medical Journal"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111137_bb1465","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1533317514524813","article-title":"Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials","volume":"29","author":"Tampi","year":"2014","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"issue":"7282","key":"10.1016\/j.pnpbp.2024.111137_bb1470","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","article-title":"Neural bases for addictive properties of benzodiazepines","volume":"463","author":"Tan","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1475","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111137_bb1480","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0028-3908(96)00065-2","article-title":"Chronic Administration of Antipanic Drugs Alters rat Brainstem GABAA receptor subunit mRNA levels","volume":"35","author":"Tanay","year":"1996","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1485","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.mp.4000879","article-title":"Common effects of chronically administered antipanic drugs on brainstem GABAA receptor subunit gene expression","volume":"6","author":"Tanay","year":"2001","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1490","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14767050802464528","article-title":"Use of diazepam for hyperemesis gravidarum","volume":"22","author":"Tasci","year":"2009","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1500","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0022-3565(24)37019-3","article-title":"Sequestration of gamma-aminobutyric acidA receptors on clathrin-coated vesicles during chronic benzodiazepine administration in vivo","volume":"283","author":"Tehrani","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1505","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/ajp.141.5.689","article-title":"Alprazolam as treatment for a case of obsessive-compulsive disorder","volume":"141","author":"Tesar","year":"1984","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111137_bb1510","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bdr2.1497","article-title":"Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011","volume":"111","author":"Tinker","year":"2019","journal-title":"Birth Defects Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1515","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamapediatrics.2021.5122","article-title":"Trends in benzodiazepine prescribing for US adolescents and Young adults from 2008 to 2019","volume":"176","author":"Toce","year":"2022","journal-title":"JAMA Pediatr."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1520","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2009.10.011","article-title":"The endogenous opioid system: a common substrate in drug addiction","volume":"108","author":"Trigo","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1525","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/da.22453","article-title":"Psychiatric comorbidity does not only depend on diagnostic thresholds: an illustration with major depressive disorder and generalized anxiety disorder","volume":"33","author":"van Loo","year":"2016","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1530","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0028-3908(02)00152-1","article-title":"Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression(1)","volume":"43","author":"Van Sickle","year":"2002","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm6801a1","article-title":"Drug overdose deaths among women aged 30-64 years - United States, 1999-2017","volume":"68","author":"VanHouten","year":"2019","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1540","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/npp.2013.258","article-title":"Neurosteroid agonist at GABAA receptor induces persistent neuroplasticity in VTA dopamine neurons","volume":"39","author":"Vashchinkina","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111137_bb1545","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1550","first-page":"1093","article-title":"Insomnia, depression and anxiety disorders and their association with benzodiazepine drug use among the community-dwelling elderly: implications for mental health nursing","volume":"10","author":"Voyer","year":"2005","journal-title":"Int. J. Psychiatr. Nurs. Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285583","article-title":"Drug prescriptions preceding opioid-related deaths-a register study in forensic autopsy patients","volume":"18","author":"Walde","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2024.111137_bb1560","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1565","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1037\/1064-1297.9.2.191","article-title":"Benzodiazepine modulation of opiate reward","volume":"9","author":"Walker","year":"2001","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1570","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(03)00043-1","article-title":"The effects of alprazolam on conditioned place preferences produced by intravenous heroin","volume":"75","author":"Walker","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1575","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pbb.2005.10.002","article-title":"Intra-ventral tegmental area heroin-induced place preferences in rats are potentiated by peripherally administered alprazolam","volume":"82","author":"Walker","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1580","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pbb.2005.10.002","article-title":"Intra-ventral tegmental area heroin-induced place preferences in rats are potentiated by peripherally administered alprazolam","volume":"82","author":"Walker","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1585","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.117.240200","article-title":"Preference for an opioid\/benzodiazepine mixture over an opioid alone using a concurrent choice procedure in Rhesus monkeys","volume":"362","author":"Weed","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1590","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.drugalcdep.2005.05.006","article-title":"Effects of GABAergic modulators on food and cocaine self-administration in baboons","volume":"80","author":"Weerts","year":"2005","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1595","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/03630242.2015.1101739","article-title":"Anxiety and rumination moderate menstrual cycle effects on mood in daily life","volume":"56","author":"Welz","year":"2016","journal-title":"Women Health"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1600","doi-asserted-by":"crossref","DOI":"10.1097\/00008877-199206000-00006","article-title":"Discriminative stimulus effects of alprazolam and diazepam: generalization to benzodiazepines, antidepressants and buspirone","volume":"3","author":"Wettstein","year":"1992","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111137_bb1605","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/CEOR.S406137","article-title":"Benzodiazepine usage, healthcare resource utilization, and costs among older adults treated with common insomnia medications: a retrospective cohort study","volume":"15","author":"Wickwire","year":"2023","journal-title":"Clinicoecon Outcomes Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1610","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1006\/bbrc.1996.0156","article-title":"Tissue distribution of opioid receptor gene expression in the rat","volume":"218","author":"Wittert","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1615","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.paf.0000153994.95642.c1","article-title":"Alprazolam-related deaths in Palm Beach County","volume":"26","author":"Wolf","year":"2005","journal-title":"Am J Forensic Med Pathol"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1620","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1530\/REP-06-0302","article-title":"Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus","volume":"133","author":"Wood","year":"2007","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111137_bb1625","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.113.203653","article-title":"Estrous cycle regulation of extrasynaptic delta-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesis","volume":"346","author":"Wu","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2024.111137_bb1630","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(98)00406-5","article-title":"Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study","volume":"798","author":"Xi","year":"1998","journal-title":"Brain Res."},{"issue":"21","key":"10.1016\/j.pnpbp.2024.111137_bb1635","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1523\/JNEUROSCI.1504-11.2011","article-title":"Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area","volume":"31","author":"Xia","year":"2011","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111137_bb1640","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0009-9236(96)90179-4","article-title":"A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism","volume":"59","author":"Yasui","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111137_bb1645","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0306-4522(99)00046-9","article-title":"Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors","volume":"92","author":"Yoshida","year":"1999","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1655","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/0091217419870669","article-title":"Relative prevalence of 10 types of pharmacodynamic interactions in psychiatric treatment","volume":"55","author":"Zarkowski","year":"2020","journal-title":"Int. J. Psychiatry Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1660","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0091217420960619","article-title":"Prevalence and socioeconomic factors in the prescription of concurrent amphetamine and alprazolam","volume":"56","author":"Zarkowski","year":"2021","journal-title":"Int. J. Psychiatry Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111137_bb1665","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00004714-199504000-00007","article-title":"Comparative abuse liability of sertraline, alprazolam, and Dextroamphetamine in humans","volume":"15","author":"Zawertailo","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111137_bb1670","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/da.22026","article-title":"Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample","volume":"29","author":"Zbozinek","year":"2012","journal-title":"Depress. Anxiety"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111137_bb1675","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0306-4522(88)90036-X","article-title":"Benzodiazepine receptor sites in the human brain: autoradiographic mapping","volume":"25","author":"Zezula","year":"1988","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111137_bb1680","first-page":"344","article-title":"Alprazolam withdrawal delirium unresponsive to diazepam: case report","volume":"46","author":"Zipursky","year":"1985","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111137_bb1685","first-page":"963","article-title":"Adverse behavioral effects of benzodiazepines","volume":"5","author":"Zisook","year":"1977","journal-title":"J. Fam. Pract."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:24:41Z","timestamp":1778682281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624002057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":340,"alternative-id":["S0278584624002057"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111137","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mother's little helper turned a foe: Alprazolam use, misuse, and abuse","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111137"}}